Fundraising Fox
Grapheal
Founded 2019 · 9 employees on LinkedIn · 3 known investors
Find your way into Grapheal
Sign up to see every warm intro you have to Grapheal
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Grapheal team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Grapheal develops graphene-based biosensors, including PFAST, a field-deployable device for fast, real-time detection of ultra-trace PFAS ("forever chemicals") in water. The platform enables point-of-need testing to support PFAS monitoring under regulations such as the EU Drinking Water Directive.
Investors · 3
How we know: Novalis Biotech's portfolio page · graphene-info.com · funding news · Not right? Tell us
How we know: graphene-info.com · funding news · Not right? Tell us
How we know: finsmes.com · Not right? Tell us
Funding
SEC filings, press & company announcementsSource: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Grapheal do?
- Grapheal develops graphene-based biosensors, including PFAST, a field-deployable device for fast, real-time detection of ultra-trace PFAS ("forever chemicals") in water. The platform enables point-of-need testing to support PFAS monitoring under regulations such as the EU Drinking Water Directive.
- Who are Grapheal's investors?
- Grapheal's investors include Novalis Biotech, Bpifrance, EIC.